Advertisement
ELDN vs VANI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELDN is a Hold and VANI is a Buy.
ELDN's Stochastic Oscillator slumps oversold zone
The Stochastic Oscillator for ELDN moved into oversold territory on November 12, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ELDN just turned positive on October 21, 2026. Looking at past instances where ELDN's MACD turned positive, the stock continued to rise in 39 of 43 cases over the following month. The odds of a continued upward trend are 90%.
The 10-day moving average for ELDN crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 19 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +16.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELDN advanced for three days, in 220 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
Bearish Trend Analysis
The 10-day RSI Indicator for ELDN moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 20 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ELDN as a result. In 78 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
ELDN moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for ELDN moved below the 200-day moving average on October 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELDN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
ELDN broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ELDN entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. ELDN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.412) is normal, around the industry mean (3.498). P/E Ratio (-2.894) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
VANI in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 12, 2026
VANI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 35 cases where VANI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VANI's RSI Oscillator exited the oversold zone, 19 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 66 cases where VANI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for VANI just turned positive on November 09, 2026. Looking at past instances where VANI's MACD turned positive, the stock continued to rise in 38 of 51 cases over the following month. The odds of a continued upward trend are 75%.
Following a +7.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where VANI advanced for three days, in 156 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VANI as a result. In 72 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The 50-day moving average for VANI moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VANI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for VANI entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.089) is normal, around the industry mean (3.498). P/E Ratio (-2.972) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. VANI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VANI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ELDN | VANI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 40 | 2 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | 68 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 59 | 70 | |
P/E GROWTH RATING 1..100 | 98 | 20 | |
SEASONALITY SCORE 1..100 | 30 | 40 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VANI's Valuation (68) in the null industry is in the same range as ELDN (72) in the Pharmaceuticals Major industry. This means that VANI’s stock grew similarly to ELDN’s over the last 12 months.
VANI's Profit vs Risk Rating (100) in the null industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that VANI’s stock grew similarly to ELDN’s over the last 12 months.
VANI's SMR Rating (100) in the null industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that VANI’s stock grew similarly to ELDN’s over the last 12 months.
ELDN's Price Growth Rating (59) in the Pharmaceuticals Major industry is in the same range as VANI (70) in the null industry. This means that ELDN’s stock grew similarly to VANI’s over the last 12 months.
VANI's P/E Growth Rating (20) in the null industry is significantly better than the same rating for ELDN (98) in the Pharmaceuticals Major industry. This means that VANI’s stock grew significantly faster than ELDN’s over the last 12 months.
| ELDN | VANI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 76% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 70% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 75% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 80% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 81% |
| Advances ODDS (%) | 4 days ago 88% | 3 days ago 75% |
| Declines ODDS (%) | 1 day ago 88% | 1 day ago 85% |
| BollingerBands ODDS (%) | 1 day ago 88% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ELDN’s FA Score shows that 0 FA rating(s) are green while VANI’s FA Score has 1 green FA rating(s).
- ELDN’s FA Score: 0 green, 5 red.
- VANI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ELDN’s TA Score shows that 4 TA indicator(s) are bullish while VANI’s TA Score has 5 bullish TA indicator(s).
- ELDN’s TA Score: 4 bullish, 7 bearish.
- VANI’s TA Score: 5 bullish, 4 bearish.
Price Growth
ELDN (@Biotechnology) experienced а -3.86% price change this week, while VANI (@Biotechnology) price change was -5.44% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.04%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -16.99%.
Reported Earning Dates
ELDN is expected to report earnings on Nov 13, 2026.
VANI is expected to report earnings on Apr 01, 2027.
Industries' Descriptions
@Biotechnology (+2.04% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ELDN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with EDIT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To ELDN | 1D Price Change % | ||
|---|---|---|---|---|
| ELDN | 100% | -11.42% | ||
| EDIT - ELDN | 50% Loosely correlated | -10.08% | ||
| BEAM - ELDN | 48% Loosely correlated | -6.90% | ||
| NTLA - ELDN | 47% Loosely correlated | -7.54% | ||
| MGX - ELDN | 46% Loosely correlated | -5.59% | ||
| PRME - ELDN | 43% Loosely correlated | -9.53% | ||
More | ||||
VANI and
Correlation & Price change
A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.
| Ticker / NAME | Correlation To VANI | 1D Price Change % | ||
|---|---|---|---|---|
| VANI | 100% | -12.97% | ||
| VTVT - VANI | 60% Loosely correlated | -3.63% | ||
| ELDN - VANI | 38% Loosely correlated | -11.42% | ||
| AZR - VANI | 37% Loosely correlated | +1.91% | ||
| NKTX - VANI | 36% Loosely correlated | -14.53% | ||
| TNXP - VANI | 36% Loosely correlated | -16.28% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BZQ | 22.18 | 0.81 | +3.81% |
| ProShares UltraShort MSCI Brazil Capped (BZQ) | |||
| BENJ | 53.56 | 0.01 | +0.02% |
| Horizon Landmark ETF (BENJ) | |||
| JPSV | 70.98 | N/A | N/A |
| JPMorgan Active Small Cap Value ETF (JPSV) | |||
| ZDEK | 27.05 | -0.01 | -0.04% |
| Innovator 1 Yr December (ZDEK) | |||
| QDPL | 45.35 | -0.16 | -0.35% |
| Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF (QDPL) | |||